Plavix safety

3252010018332FDA Drug Safety Communication: Reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug. Safety Announcement The Related Drug Information Index provides comprehensive access to all drug information related to a specific drug Types of content include full prescribing

Learn about the potential side effects of Plavix (clopidogrel). Includes common and rare side effects information for consumers and healthcare professionals

12202014018332Learn about drug side effects and interactions for the drug Plavix (Clopidogrel Bisulfate) Find patient medical information for Plavix oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings Clopidogrel (INN) is an oral, thienopyridine -class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease

FDA Drug Safety Communication: Reduced effectiveness of

6 Pediatric Labeling Change Plavix174 (clopidogrel) 8 USE IN SPECIFIC POPULATIONS 8.4 Pediatric Use Safety and effectiveness in pediatric populations have not been Easy to read patient leaflet for Plavix. Includes indications, proper use, special instructions, precautions, and possible side effects

Important safety information about Plavix: This medicine must be converted in the body for it to work. This conversion does not occur as well in some people 12212014018332Learn about clinical pharmacology for the drug Plavix (Clopidogrel Bisulfate)